Biologically active γ-lactams: synthesis and natural sources

J Caruano, GG Muccioli, R Robiette - Organic & biomolecular …, 2016 - pubs.rsc.org
The γ-lactam moiety is present in a large number of natural and non-natural biologically
active compounds. The range of biological activities covered by these compounds is very …

Sulfoxonium ylides: simple compounds with chameleonic reactivity

GD Bisag, S Ruggieri, M Fochi… - Organic & Biomolecular …, 2020 - pubs.rsc.org
Sulfur ylides first disclosed in 1930 started to gain more attention in the 1960s, thanks mainly
to the studies by Corey and Chaykovsky on their use for the preparation of strained rings …

Natural product synthesis using multicomponent reaction strategies

BB Toure, DG Hall - Chemical Reviews, 2009 - ACS Publications
The preparation of urea by Wöhler constituted a landmark achievement in organic chemistry,
and it laid the ground for the early days of target-oriented organic synthesis. 1 Since then …

Impact of natural products on developing new anti-cancer agents

GM Cragg, PG Grothaus, DJ Newman - Chemical reviews, 2009 - ACS Publications
Throughout the ages, Nature has catered to the basic needs of humans, not the least of
which is the provision of medicines for the treatment of a wide spectrum of diseases. Plants …

Proteasome inhibitor drugs

LD Fricker - Annual review of pharmacology and toxicology, 2020 - annualreviews.org
Proteasomes are large, multicatalytic protein complexes that cleave cellular proteins into
peptides. There are many distinct forms of proteasomes that differ in catalytically active …

[HTML][HTML] Hypoxia-inducible factor 1α (HIF-1α) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions: its stabilization by hypoxia …

S Salceda, J Caro - Journal of Biological Chemistry, 1997 - ASBMB
The hypoxia-inducible factor 1 transcriptional activator complex (HIF-1) is involved in the
activation of the erythropoietin and several other hypoxia-responsive genes. The HIF-1 …

[PDF][PDF] Salinosporamide A: A Highly Cytotoxic Proteasome Inhibitor from a Novel Microbial Source, a Marine Bacterium of the New Genus Salinospora

RH Feling, GO Buchanan, TJ Mincer… - Angewandte Chemie …, 2003 - academia.edu
We recently reported the cultivation and phylogenetic characterization of a new group of
obligate marine actinomycete bacteria that is widely distributed in ocean sediments.[1] …

Natural products to drugs: natural product-derived compounds in clinical trials

MS Butler - Natural product reports, 2008 - pubs.rsc.org
Covering: 2005 to 2007 Natural product and natural product-derived compounds that are
being evaluated in clinical trials or are in registration (as at 31st December 2007) have been …

[PDF][PDF] Proteasome inhibitors: from research tools to drug candidates

AF Kisselev, AL Goldberg - Chemistry & biology, 2001 - cell.com
The 26S proteasome is a 2.4 MDa multifunctional ATP-dependent proteolytic complex,
which degrades the majority of cellular polypeptides by an unusual enzyme mechanism …

Developing a new resource for drug discovery: marine actinomycete bacteria

W Fenical, PR Jensen - Nature chemical biology, 2006 - nature.com
Natural products are both a fundamental source of new chemical diversity and an integral
component of today's pharmaceutical compendium. Yet interest in natural-product drug …